Publishes | Daily | Episodes | 84 | Founded | 10 years ago |
---|---|---|---|---|---|
Number of Listeners | Categories | MedicineHealth & Fitness |
If you’re a woman going through menopause you may have chosen to go online for help. If so you may be the victim of a ‘femtech’ company. Wen Shen, a menopause expert at Johns Hopkins, explains. Shen: Basically they're there to push compounded hormone... more
Women may be experiencing overmedicalization as they transition through menopause, a recent Lancet series seems to suggest. Wen Shen, a menopause expert at Johns Hopkins, says that’s not her experience, since she sees many women who avoid physicians ... more
A recent Lancet series on menopause may result in many more women turning to the internet for help. That’s according to Wen Shen, a menopause expert at Johns Hopkins, who fears the series may have set back progress on bringing awareness to clinicians... more
As women transition through menopause, they should be offered conservative approaches that don’t rely on medicines. That’s one interpretation of a recent Lancet series on menopause, and Wen Shen, a menopause expert at Johns Hopkins, says while such a... more
Is menopause overmedicalized? That seems to be one conclusion of a recent series published in the Lancet on this life stage for women. Wen Shen, a menopause expert at Johns Hopkins, begs to disagree. Shen: It's unfortunate that they came across with ... more
An injectable drug called omalizumab now may be used to manage severe food allergies, the FDA has decided. Robert Wood, an allergy expert at Johns Hopkins, says the drug will only work if people are taking it. Wood: This is a therapy that will only w... more
Omalizumab is an injectable drug just approved by the FDA to treat severe food allergies. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says risks discerned in the study were very smal... more
Consequences of food allergies can be life-threatening, which is why FDA approval of omalizumab to treat them is welcome. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says it’s not yo... more
Find out how many people listen to Health Newsfeed – Johns Hopkins Medicine Podcasts and see how many downloads it gets.
We scanned the web and collated all of the information that we could find in our comprehensive podcast database.
Listen to the audio and view podcast download numbers, contact information, listener demographics and more to help you make better decisions about which podcasts to sponsor or be a guest on.
Apple Podcasts | #38 | China/Health & Fitness/Medicine |
Apple Podcasts | #51 | South Korea/Health & Fitness/Medicine |
Apple Podcasts | #145 | New Zealand/Health & Fitness/Medicine |
Apple Podcasts | #193 | Sweden/Health & Fitness/Medicine |
Apple Podcasts | #209 | Mexico/Health & Fitness/Medicine |
Apple Podcasts | #243 | China/Health & Fitness |
Listeners, engagement and demographics and more for this podcast.
Listeners per Episode | Gender Skew | Engagement Score | |||
---|---|---|---|---|---|
Primary Location | Social Media Reach |
Rephonic provides a wide range of data for three million podcasts so you can understand how popular each one is. See how many people listen to this podcast and access YouTube viewership numbers, download stats, chart rankings, ratings and more.
Simply upgrade your account and use these figures to decide if the show is worth pitching as a guest or sponsor.
There are two ways to find viewership numbers for podcasts on YouTube. First, you can search for the show on the channel and if it has an account, scroll through the videos to see how many views it gets per episode.
Rephonic also pulls the total number of views for each podcast we find a YouTube account for. You can access these figures by upgrading your account and looking at a show's social media section.
Podcast streaming numbers or 'plays' are notoriously tricky to find. Fortunately, Rephonic provides estimated listener figures for this podcast and three million other podcasts in our database.
To check these stats and get a feel for the show's audience size, you'll need to upgrade your account.
To see how many followers or subscribers this podcast has, simply upgrade your account. You'll find a whole host of extra information to help you decide whether appearing as a sponsor or guest on this podcast is right for you or your business.
If it's not, use the search tool to find other podcasts with subscriber numbers that match what you're looking for.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. You can see some of this data for free. But you will need to upgrade your account to access premium data.
this podcast launched 10 years ago and published 84 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contact information for you.
Our systems scan a variety of public sources including the podcast's official website, RSS feed, and email databases to provide you with a trustworthy source of podcast contact information. We also have our own research team on-hand to manually find email addresses if you can't find exactly what you're looking for.
Rephonic pulls reviews for this podcast from multiple sources, including Apple Podcasts, Castbox, Podcast Addict and more.
View all the reviews in one place instead of visiting each platform individually and use this information to decide whether this podcast is worth pitching as a guest or sponsor.
You can view podcasts similar to this podcast by exploring Rephonic's 3D interactive graph. This tool uses the data displayed on the 'Listeners Also Subscribed To' section of Apple Podcasts to visualise connections between shows.